期刊文献+

脑胶质瘤中ppENK、EDNRB和CLDN-7基因甲基化状态的研究 被引量:3

Methylation of ppENK,EDNRB and CLDN-7 gene in glioma
下载PDF
导出
摘要 目的 了解脑胶质瘤中ppENK、EDNRB和CLDN-7 3种基因的甲基化状况.方法 应用巢式聚合链式反应(nPCR)方法和亚硫酸氢盐修饰后测序(BSP)方法,分别检测46例脑胶质瘤标本和10例正常脑组织标本的3种基因启动子区CpG岛的甲基化状态,并分析各基因甲基化程度与临床资料的关系.结果 正常脑组织标本中该3种基因无甲基化.脑胶质瘤中ppENK、EDNRB和CLDN-7 3种基因启动子甲基化率分别为44.2%(19/43)、22.5% (9/40)和0% (0/5).在低级别(Ⅰ~Ⅱ级)脑胶质瘤组中ppENK基因启动子甲基化率(33.3%)低于高级别(Ⅲ~Ⅳ级)脑胶质瘤组中ppENK基因启动子甲基化率(69.2%),两者差异具有统计学意义(P<0.05).结论 脑胶质瘤中ppENK和EDNRB基因启动子区CpG岛有甲基化现象,与脑胶质瘤发生、发展有关. Objective To study the methylation of ppENK,EDNRB and CLDN-7 in glioma.Methods nPCR and BSP were adopted to investigate the promoter frequency of these genes in 46 cases of glioma and 10 normal brain tissue.The relationship between frequency of methylation of these genes and clinical disease material was analyzed.Results Normal brain tissue had no genes methylation.In patientions with glioma,the frequency of methylation in ppENK,EDNRB and CLDN-7 was 44.2% (19/43),22.5 % (9/40) and 0% (0/5).The rate (33.3%) of ppENK promoter methylation in grades Ⅰ ~ Ⅱ gliomas was significantly lower than that (69.2%) in grades Ⅲ ~ Ⅳ gliomas (P < 0.05).Conclusion ppENK and EDNRB promoter (CpG island)hypermethylation exists in glioma,which may correlate with the occurrence of glioma.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第8期1124-1127,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽省卫生厅基金(编号:2010B013)
关键词 CPG岛 甲基化 胶质瘤 CpG Methylation glioma
  • 相关文献

参考文献13

  • 1Ueki T, Toyota M, Skinner H, et al. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma[J]. Cancer Res, 2001,61 (23) :8540 -6.
  • 2KaurJ, Demokan S, Tripathi S C, et al. Promoter hypennethylation in Indian primary oral squamous cell carcinoma[J]. IntJ Cancer, 2010 ,127 (10) :2367 -73.
  • 3Yates DR, Rehman I, Abbod M F, et al. Promoter hypennethylation identifies progression risk in bladder cancer[J]. Clin Cancer Res, 2007 ,13(7) :2046 -53.
  • 4Kojima T, Sawada N. Regulation of tightJunctions in human normal pancreatic duct epithelial cells and cancer cells[J]. Ann N Y Acad Sci, 2012,1257(10) :85 -92.
  • 5Lee K H, LeeJ S, NamJ H, et al. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associat- ed with adenoma-carcinoma sequence[J]. Langenbecks Arch Surg, 2011 ,396(7) :1017 -26.
  • 6Berrada N, Amzazi S, Ameziane El Hassani R, et al. Epigenetic alterations of adenomatous polyposis coli (APC) , retinoic acid receptor beta (RARJ3) and survivin genes in tumor tissues and voided urine of bladder cancer patients[J]. Cell Mol Biol (Noisy-legrand), 2012 ,Supp158 :0L1744 -51.
  • 7PaluszczakJ, Misiak P, Wierzbicka M, et al. Frequent hypennethylation of DAPK, RARbeta, MGMT, RASSFI A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa[J]. Oral Oncol, 2011,47(2) :104 -7.
  • 8Nalejska E, Maczynska E, Lewandowska M A. Prognostic and predictive biomarkers: tools in personalized oncology[J]. Mol Diagn Ther, 2014,18 (3) :273 - 84.
  • 9Yang L, Yang H, LiJ, et al. ppENK gene methylation status in the development of pancreatic carcinoma[J]. Gastroenterol Res Pract, 2013, 2013: 130927.
  • 10Zhang Y, Yang B, Du Z, et al. Identification and validation of specific methylation profile in bile for differential diagnosis of malignant biliary stricture[J]. Clin Biochem, 2010, 43(16 -17): 1340 -4.

同被引文献38

  • 1王自勇,王鹏,杨渭川,葛锐.大鼠C6脑胶质瘤生长规律的MRI与病理学观察[J].安徽医学,2009,30(12):1423-1426. 被引量:3
  • 2王伟民,朱诚,张光霁,蔡如珏,胡加飞,张建民,叶挺军.脑立体定向接种C_6细胞建立大鼠脑胶质瘤模型[J].中华实验外科杂志,1995,12(4):221-222. 被引量:13
  • 3陈伟,刘华一.中医药防治胃癌前病变机制的实验研究进展[J].天津中医药大学学报,2007,26(1):54-56. 被引量:25
  • 4Garcia P, Leal P, Ili C, et al. Inhibition of connective tissue growth factor (CTGF/CCN2) in gallbladder cancer cells leads to decreased growth in vitro[J].Int J Exp Pathol, 2013, 94(3): 195-202.
  • 5Hishikawa K, Oemar BS,Tanner FC, et al. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7[J]. J Biol Chem, 1999, 274(52):37461-37466.
  • 6Lee HK, Bier A, Cazacu S, et al. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor [J]. PLoS One, 2013,8(2):e54652.
  • 7Brait M, Ling S, Nagpal J K, et al. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers[J]. PLoS One,2012, 7(9) :e44951.
  • 8Ueno K, Kumagai T, Kijima T, et al. Cloning and tissue expres- sion of cDNAs from chromosome 5q21-22 which is frequently dele- ted in advanced lung cancer[J]. Human Genet, 1998, 102( 1 ) : 63 - 8.
  • 9Yamashita K, Waraya M, Kim M S, et al. Detection of methyla- ted CDO1 in plasma of coloreetal cancer; a PER study[ J]. PLoS One, 2014, 9(12) :e113546.
  • 10. Dietrich D, Krispin M, Dietrich J, et al. CDO1 promoter methyla- tion is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer pa- tients[J]. BMC Cancer, 2010, 10:247.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部